M&A values in healthcare decreased by over 60% in Q3 2017 compared to Q2, but volume remains consistent, led by biotech and pharma.
Life-saving gene therapies are within patients’ grasp, but for most, financially out of reach, creating a quandary for insurers and healthcare executives.
Succeeding in the Middle East and Africa, despite unpredictability, is a matter of strategic adaptation.
Our discussion with Dr. Catherine Zahn, President & CEO of Centre for Addiction and Mental Health, on career drivers, leadership, and the diversity challenges that continue to face us today.
Our discussion with Alayne Metrick – President, St. Michael’s Hospital Foundation on leadership, diversity, team drivers and advice to the next generation.
Despite uncertainties in other sections of the US healthcare industry, those in the business of life science tools and services are riding high.
Boyden’s Aurea Imai shares insights on the local market for executive talent in healthcare and life sciences.
The president of Bayer Brazil shares his views on how to keep a workforce innovative, socially aware and ahead of the competition.
In what is China’s biggest-yet foreign acquisition, state-owned ChemChina is set to acquire Swiss agribusiness giant Syngenta.